| Name | Title | Contact Details |
|---|---|---|
Kimberly Burak |
Chief People Officer | Profile |
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Fond Du Lac Lutheran Home Inc is a Fond Du Lac, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Flexion Therapeutics (NASDAQ: FLXN) is a biopharmaceutical company focused on the discovery, development & commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions. Flexion is based in Burlington, Massachusetts.
Athens Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Athens Regional Medical Center is based in Athens, GA. You can find more information on Athens Regional Medical Center at www.armc.org
Centrad Healthcare Inc is a Naperville, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.